Cargando…

Modeling the mature CNS: A predictive screening platform for neurodegenerative disease drug discovery

BACKGROUND: Mature primary neuronal cultures are an important model of the nervous system, but limited scalability has been a major challenge in their use for drug discovery of neurodegenerative diseases. This work describes a method for improving scalability through the use of larger format microti...

Descripción completa

Detalles Bibliográficos
Autores principales:	LaBarbera, Kelsie Mozzoni, Limegrover, Colleen, Rehak, Courtney, Yurko, Raymond, Izzo, Nicholas John, Knezovich, Nicole, Watto, Emily, Waybright, Lora, Catalano, Susan M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217273/ https://www.ncbi.nlm.nih.gov/pubmed/33836174 http://dx.doi.org/10.1016/j.jneumeth.2021.109180

Ejemplares similares

Sigma‐2 receptor antagonists rescue neuronal dysfunction induced by Parkinson’s patient brain‐derived α‐synuclein
por: Limegrover, Colleen S., et al.
Publicado: (2021)

Alzheimer’s protection effect of A673T mutation may be driven by lower Aβ oligomer binding affinity
por: Limegrover, Colleen S., et al.
Publicado: (2020)

Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification
por: Izzo, Nicholas J., et al.
Publicado: (2021)

A phase 1b randomized clinical trial of CT1812 to measure Aβ oligomer displacement in Alzheimer’s disease using an indwelling CSF catheter
por: LaBarbera, Kelsie M., et al.
Publicado: (2023)

Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers II: Sigma-2/PGRMC1 Receptors Mediate Abeta 42 Oligomer Binding and Synaptotoxicity
por: Izzo, Nicholas J., et al.
Publicado: (2014)

CNS Ageing in Health and Neurodegenerative Disorders
por: Kesidou, Evangelia, et al.
Publicado: (2023)

Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers I: Abeta 42 Oligomer Binding to Specific Neuronal Receptors Is Displaced by Drug Candidates That Improve Cognitive Deficits
por: Izzo, Nicholas J., et al.
Publicado: (2014)

High-Throughput Screening Platforms in the Discovery of Novel Drugs for Neurodegenerative Diseases
por: Aldewachi, Hasan, et al.
Publicado: (2021)

TREM2 in CNS homeostasis and neurodegenerative disease
por: Painter, Meghan M., et al.
Publicado: (2015)

CNS Redox Homeostasis and Dysfunction in Neurodegenerative Diseases
por: Goldsteins, Gundars, et al.
Publicado: (2022)

Targeting HIV-1 Protease Autoprocessing for High-throughput Drug Discovery and Drug Resistance Assessment
por: Huang, Liangqun, et al.
Publicado: (2019)

STING-Triggered CNS Inflammation in Human Neurodegenerative Diseases
por: Ferecskó, Alex S., et al.
Publicado: (2023)

Occipital intermittent rhythmic delta activity (OIRDA) in pediatric focal epilepsies: A case series
por: LaBarbera, Vincent, et al.
Publicado: (2021)

A phase 1 clinical trial of the sigma-2 receptor complex allosteric antagonist CT1812, a novel therapeutic candidate for Alzheimer's disease
por: Grundman, Michael, et al.
Publicado: (2019)

CNS Infiltration of Peripheral Immune Cells: D-Day for Neurodegenerative Disease?
por: Rezai-Zadeh, Kavon, et al.
Publicado: (2009)

Invasive aspergillosis in an immunocompetent patient with fever and a cardiac mass
por: LaBarbera, Matthew, et al.
Publicado: (2011)

High-Content Drug Discovery Targeting Molecular Bladder Cancer Subtypes
por: Rinaldetti, Sébastien, et al.
Publicado: (2022)

The Current Challenges for Drug Discovery in CNS Remyelination
por: Balestri, Sonia, et al.
Publicado: (2021)

Live Multicellular Tumor Spheroid Models For High-Content Imaging and Screening In Cancer Drug Discovery
por: Reid, Brian G., et al.
Publicado: (2014)

TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease
por: McCoy, Melissa K, et al.
Publicado: (2008)

The Diverse Roles of Microglia in the Neurodegenerative Aspects of Central Nervous System (CNS) Autoimmunity
por: Thompson, Kaitlyn K., et al.
Publicado: (2017)

P2X7 Receptors Amplify CNS Damage in Neurodegenerative Diseases
por: Illes, Peter
Publicado: (2020)

Novel CSF Biomarkers Tracking Autoimmune Inflammatory and Neurodegenerative Aspects of CNS Diseases
por: Kapaki, Elisabeth, et al.
Publicado: (2022)

Contribution of Extracellular Vesicles and Molecular Chaperones in Age-Related Neurodegenerative Disorders of the CNS
por: Noori, Leila, et al.
Publicado: (2023)

A Microfluidic Platform for the Characterisation of CNS Active Compounds
por: MacKerron, Christopher, et al.
Publicado: (2017)

Strategies to facilitate the discovery of novel CNS PET ligands
por: Zhang, Lei, et al.
Publicado: (2016)

An Extracellular Perspective on CNS Maturation: Perineuronal Nets and the Control of Plasticity
por: Carulli, Daniela, et al.
Publicado: (2021)

Developmental ablation of mature oligodendrocytes exacerbates adult CNS demyelination
por: Pajoohesh-Ganji, Ahdeah, et al.
Publicado: (2020)

Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery
por: Ghose, Arup K., et al.
Publicado: (2011)

The Use of Proteomics in Biomarker Discovery in Neurodegenerative Diseases
por: Davidsson, Pia, et al.
Publicado: (2005)

Transport characteristics of a novel peptide platform for CNS therapeutics
por: Bertrand, Yanick, et al.
Publicado: (2010)

Multifaceted Roles of Metzincins in CNS Physiology and Pathology: From Synaptic Plasticity and Cognition to Neurodegenerative Disorders
por: Brzdak, Patrycja, et al.
Publicado: (2017)

Resident Memory-like CD8(+) T Cells Are Involved in Chronic Inflammatory and Neurodegenerative Diseases in the CNS
por: Kimura, Kimitoshi, et al.
Publicado: (2023)

Risk in CNS drug discovery: focus on treatment of Alzheimer's Disease
por: Pritchard, J Fred
Publicado: (2008)

Meeting the unique challenges of drug discovery for neurodegenerative diseases
por: Shineman, Diana W, et al.
Publicado: (2009)

Proteomic Approaches for the Discovery of Biofluid Biomarkers of Neurodegenerative Dementias
por: Carlyle, Becky C., et al.
Publicado: (2018)

Curcumin as Scaffold for Drug Discovery against Neurodegenerative Diseases
por: Lo Cascio, Filippa, et al.
Publicado: (2021)

Application of Sebum Lipidomics to Biomarkers Discovery in Neurodegenerative Diseases
por: Briganti, Stefania, et al.
Publicado: (2021)

Mushroom Natural Products in Neurodegenerative Disease Drug Discovery
por: Abitbol, Arjuna, et al.
Publicado: (2022)

Mature oligodendrocytes actively increase in vivo cytoskeletal plasticity following CNS damage
por: Locatelli, Giuseppe, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_h6mem0o5ls0fhkj629sk68i1ef